Recombinant Human Lactoferrin Modulates Human PBMC Derived Macrophage Responses to BCG and LPS

This report is the first to demonstrate the effects of a recombinant human lactoferrin (10 μg/mL) on human PBMC derived CD14+ and CD16+ macrophages stimulated with a strong (LPS, 10ng/mL) or weaker (BCG, MOI 1:1) stimulator of inflammation.

Source: Tuberculosis - September 26, 2016 Category: Respiratory Medicine Authors: Shen-An Hwang, Marian L. Kruzel, Jeffrey K. Actor Source Type: research